REG Stock Analysis: Regency Centers | NASDAQ
REIT - Retail | NASDAQ, USA | Market Cap: 15.293m USD | 12M Return: 16.2% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 129M
EPS Trend: 70.1%
Qual. Beats: 0
Rev. Trend: 98.2%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Regency Centers Corporation (NASDAQ: REG) is a Jacksonville, Florida-based real estate investment trust (REIT) that has operated as a publicly traded company since 1993 and has been an S&P 500 Index constituent since 2017. Founded in 1963, Regency owns, operates, acquires, and develops neighborhood and community shopping centers located in suburban trade areas across the United States, with a tenant base anchored by grocers, restaurants, and service providers alongside other retailers. As a self-administered and self-managed REIT, it conducts the substantial majority of its business directly through its consolidated operations and assets. Regency falls within the Retail REITs sub-industry of the Real Estate sector.
Like other U.S. REITs, Regency is generally required to distribute the majority of its taxable income to shareholders in the form of dividends, a structural feature that distinguishes REITs from conventional corporations. Its focus on grocery-anchored neighborhood and community centers positions it within a retail REIT category that is typically viewed as more resilient to e-commerce pressure than larger mall formats, given the day-to-day necessity of food and convenience shopping.
- Same-property NOI growth from positive leasing spreads
- Interest rate hikes pressure cap rates and acquisition yields
- Grocer-anchored centers drive leasing demand and occupancy
| Net Income: 648.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA -1.74 > 1.0 |
| NWC/Revenue: 8.45% < 20% (prev -16.06%; Δ 24.50% < -1%) |
| CFO/TA 0.06 > 3% & CFO 819.4m > Net Income 648.7m |
| Net Debt (6.04b) to EBITDA (1.16b): 5.21 < 3 |
| Current Ratio: 1.53 > 1.5 & < 3 |
| Outstanding Shares: last quarter (183.4m) vs 12m ago 0.86% < -2% |
| Gross Margin: 47.88% > 18% (prev 71.09%; Δ -23.21% > 0.5%) |
| Asset Turnover: 13.29% > 50% (prev 12.12%; Δ 1.17% > 0%) |
| Interest Coverage Ratio: 3.54 > 6 (EBIT TTM 751.6m / Interest Expense TTM 212.2m) |
| A: 0.01 (Total Current Assets 413.2m - Total Current Liabilities 269.5m) / Total Assets 13.0b |
| B: -0.15 (Retained Earnings -2.00b / Total Assets 13.0b) |
| C: 0.06 (EBIT TTM 751.6m / Avg Total Assets 12.8b) |
| D: 1.17 (Book Value of Equity 6.89b / Total Liabilities 5.88b) |
| Altman-Z'' = 1.20 = BB |
| DSRI: 0.90 (Receivables 267.6m/266.7m, Revenue 1.70b/1.52b) |
| GMI: 1.48 (GM 71.09% / 47.88%) |
| AQI: 1.00 (AQ_t 0.94 / AQ_t-1 0.95) |
| SGI: 1.12 (Revenue 1.70b / 1.52b) |
| TATA: -0.01 (NI 648.7m - CFO 819.4m) / TA 13.0b) |
| Beneish M = -2.59 (Cap -4..+1) = A |
As of July 02, 2026, the stock is trading at USD 79.37 with a total of 1,561,684 shares traded. Over the past week, the price has changed by -0.63%, over one month by +5.23%, over three months by +5.27% and over the past year by +16.19%.
Current recommended Stop Loss: 77.40 (which is 2.5% or 1.5 ATR below the current price).
Regency Centers has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy REG.
- StrongBuy: 9
- Buy: 3
- Hold: 9
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 84.6 | 6.6% |
P/E Trailing = 28.1134
P/E Forward = 35.0877
P/S = 9.2659
P/B = 2.2465
P/EG = 2.7008
Revenue TTM = 1.70b USD
EBIT TTM = 751.6m USD
EBITDA TTM = 1.16b USD
Long Term Debt = 4.97b USD (from longTermDebt, last quarter)
Short Term Debt = 269.5m USD (from shortTermDebt, last quarter)
Debt = 6.19b USD (from shortLongTermDebtTotal, last quarter) + Leases 593.2m
Net Debt = 6.04b USD (calculated: Debt 6.19b - CCE 145.6m)
Enterprise Value = 21.3b USD (15.3b + Debt 6.19b - CCE 145.6m)
Interest Coverage Ratio = 3.54 (Ebit TTM 751.6m / Interest Expense TTM 212.2m)
EV/FCF = 36.37x (Enterprise Value 21.3b / FCF TTM 586.6m)
FCF Yield = 2.75% (FCF TTM 586.6m / Enterprise Value 21.3b)
FCF Margin = 34.47% (FCF TTM 586.6m / Revenue TTM 1.70b)
Net Margin = 38.12% (Net Income TTM 648.7m / Revenue TTM 1.70b)
Gross Margin = 47.88% ((Revenue TTM 1.70b - Cost of Revenue TTM 887.0m) / Revenue TTM)
Gross Margin QoQ = 18.48% (prev 55.22%)
Tobins Q-Ratio = 1.64 (Enterprise Value 21.3b / Total Assets 13.0b)
Interest Expense / Debt = 3.43% (Interest Expense 212.2m / Debt 6.19b)
Taxrate = 21.0% (US federal default 21%)
NOPAT = 593.7m (EBIT 751.6m * (1 - 21.00%))
Current Ratio = 1.53 (Total Current Assets 413.2m / Total Current Liabilities 269.5m)
Debt / Equity = 0.90 (Debt 6.19b / totalStockholderEquity, last quarter 6.89b)
Debt / EBITDA = 5.21 (Net Debt 6.04b / EBITDA 1.16b)
Debt / FCF = 10.30 (Net Debt 6.04b / FCF TTM 586.6m)
Total Stockholder Equity = 6.82b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.07% (Net Income 648.7m / Total Assets 13.0b)
RoE = 9.51% (Net Income TTM 648.7m / Total Stockholder Equity 6.82b)
RoCE = 6.37% (EBIT 751.6m / Capital Employed (Equity 6.82b + L.T.Debt 4.97b))
RoIC = 4.58% (NOPAT 593.7m / Invested Capital 13.0b)
WACC = 5.07% (E(15.3b)/V(21.5b) * Re(6.02%) + D(6.19b)/V(21.5b) * Rd(3.43%) * (1-Tc(0.21)))
Discount Rate = 6.02% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -6.67 | Cagr: -0.38%
[DCF] Terminal Value 73.10% ; FCFF base≈665.4m ; Y1≈583.5m ; Y5≈471.4m
[DCF] Fair Price = 8.31 (EV 7.57b - Net Debt 6.04b = Equity 1.52b / Shares 183.1m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 70.10 | EPS CAGR: 9.77% | SUE: 0.36 | # QB: 0
Revenue Correlation: 98.19 | Revenue CAGR: 10.02% | SUE: 0.54 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.59 | Chg30d=-2.47% | Revisions=+14% | Analysts=5
EPS current Year (2026-12-31): EPS=2.44 | Chg30d=+0.57% | Revisions=+50% | GrowthEPS=-13.4% | GrowthRev=+8.6%
EPS next Year (2027-12-31): EPS=2.51 | Chg30d=-0.77% | Revisions=-20% | GrowthEPS=+3.0% | GrowthRev=+4.1%
[Analyst] Revisions Ratio: +50%